1. Wiesenberg, I., Missbach, M., Kahlen, J.-P.,
Schräder, M. and Carlberg, C. Transcriptional activation of the
nuclear receptor RZRa by the pineal gland
hormone melatonin and identification of CGP 52608 as a synthetic ligand.
(1995) Nucl. Acids Res. 23, 327-333 (Impact factor1995
4.3).
PDF-FILE
2. Schräder, M., Nayeri, S., Kahlen, J.-P., Müller, K.M. and Carlberg, C.
Natural vitamin D3 response elements formed by inverted palindromes:
polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated
transactivation. (1995) Mol. Cell. Biol.15, 1154-1161 (Impact factor1995
10.5). PDF-FILE
3. Steinhilber, D., Brungs, M., Werz, O., Wiesenberg, I., Danielsson,
C., Kahlen, J.-P., Nayeri, S., Schräder, M. and Carlberg, C. The
nuclear receptor for melatonin represses 5-lipoxygenase gene expression in
human B lymphocytes. (1995) J. Biol. Chem. 270, 7037-7040 (Impact factor1995
7.4). PDF-FILE
4. Nayeri, S., Danielsson, C., Kahlen, J.-P., Schräder, M. Mathiasen,
I., Binderup, L. and Carlberg, C. The anti-proliferative effect of
vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but
may be related to promoter selectivity. (1995) Oncogene 11, 1853-1858 (Impact
factor1995 8.0). PDF-FILE |
|
|
|
